Still, we have not analyzed inflammation-based prognostic scores, especially the ones that use C-reactive protein such as modified Glasgow prognostic score, to draw a conclusion that PLR is the best single prognostic parameter in breast cancer. This evidence concerns the gene CRP and breast cancer.